Andreas Blesl

Medical University of Graz

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Microbiology Microbiology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Alexander R Moschen

Professor of Medicine

Johannes Kepler University Linz

AUSTRIA

View details

Piotr Eder

Assoc. Prof.

Poznan University of Medical Sciences

POLAND

View details

Christoph Högenauer

Medical University of Graz

AUSTRIA

View details

Sarah Bencardino

Vita-Salute San Raffaele University

ITALY

View details

Gregor Gorkiewicz

Medical University of Graz

AUSTRIA

View details

Simon Reider

AUSTRIA

View details

Silvio Waschina

Kiel University

GERMANY

View details

Edoardo Savarino

Associate Professor

University of Padua

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Blesl

Research Interests

Explore related searches

Contact this professor

Articles (10)

Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study

Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study

The Fecal Microbiome of IBD Patients Is Less Divertible by Bowel Preparation Compared to Healthy Controls: Results From a Prospective Study.

Filgotinib bei Colitis ulcerosa: ein Review

Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition—A Prospective Multicenter Study

Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial

Hematopoietic Stem Cell Transplantation in Refractory Crohn's Disease: Should It Be Considered?

Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective study.

Editorial: does anti-TNF ‘treatment persistence’ always equate to ‘effective treatment’? Only objective disease assessments can answer the question. Authors' reply

Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study

Collaborators (8)

Alexander R Moschen

Piotr Eder

Christoph Högenauer

Sarah Bencardino

Gregor Gorkiewicz

Simon Reider

Silvio Waschina

Edoardo Savarino

Make your next move.